Observational studyFrontiers in public health2026
ArtsRx as an arts prescribing model: leveraging CRM data to understand participation and engagement.
Observational study in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Arts prescribing programs, through which health and social care providers refer patients to arts-based activities to support health and wellbeing, are emerging in the United States but remain heterogeneous in design and implementation. Moreover, many community-based models lack consistent, technology-enabled engagement tracking systems for tracking attendance, engagement, and longitudinal participation, limiting evaluation and quality improvement. To address this gap, ArtsRx, a program developed and managed by an anchor cultural institution in New Jersey, leverages a customer relationship management (CRM) platform to capture real-time registration, attendance, and engagement data. This study presents a 2-year analysis of ArtsRx participation patterns and modifiers of engagement. Methods: This retrospective observational study was done via quantitative analysis of de-identified records for 498 individuals referred to ArtsRx between 2023 and 2025. Data extracted from the program's CRM were used to categorize engagement (no, low, medium, high). Descriptive statistics were calculated for engagement rates and examined by demographic characteristics (age, race/ethnicity, gender) and referral source. Results: Among 498 participants, 21.9% completed the program, 45.7% withdrew, 19.3% remained enrolled, and 13.1% submitted an intake form without fully enrolling. Engagement analyses focused on 336 participants who completed or withdrew. Completers attended a mean of 78.2% of scheduled activities, compared with 8.7% among withdrawn participants. Engagement level was associated with program year and referral source but not with race/ethnicity or gender; referral patterns varied by program year and participant demographics. Conclusions: This analysis demonstrates the feasibility of a CRM-based platform for monitoring engagement in U.S. arts prescribing programs. Participation patterns indicate consistent engagement across demographic groups, with variations linked to referral pathways and program year. These findings support the use of technology-enabled infrastructure for strengthening and scaling arts prescribing models within health and community care systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.